This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Ten-eleven translocation protein 1 modulates medulloblastoma progression
Genome Biology Open Access 29 April 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Accession codes
References
MacDonald, T.J. et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat. Genet. 29, 143–152 (2001).
Ellison, D.W., Clifford, S.C., Gajjar, A. & Gilbertson, R.J. What's new in neuro-oncology? Recent advances in medulloblastoma. Eur. J. Paediatr. Neurol. 7, 53–66 (2003).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Gilbertson, R., Clifford, S. PDGFRB is overexpressed in metastatic medulloblastoma. Nat Genet 35, 197–198 (2003). https://doi.org/10.1038/ng1103-197
Issue Date:
DOI: https://doi.org/10.1038/ng1103-197
This article is cited by
-
Targeting Angiogenic Factors for the Treatment of Medulloblastoma
Current Treatment Options in Oncology (2022)
-
Ten-eleven translocation protein 1 modulates medulloblastoma progression
Genome Biology (2021)
-
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRβ Aptamer
Molecular Therapy (2014)
-
Angiogenesis and Angiogenic Tyrosine Kinase Receptor Expression in Pediatric Brain Tumors
Pathology & Oncology Research (2014)
-
Impact of Molecular Biology Studies on the Understanding of Brain Tumors in Childhood
Current Oncology Reports (2012)